Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .Shares of biopharmaceutical concern Keros Therapeutics, Inc. (NASDAQ: KROS ) are trading at a small discount to cash after officially abandoning its cibotercept program, leaving it one wholly owned asset. With a 2025 that has so far fea ...